VOLUME 61   2000   NUMBER 8

Brainstorms

547 Paying Attention to Your Acetylcholine, Part 1: Structural Organization of Nicotinic Receptors. Stephen M. Stahl
[PDF]

Original Articles

549 Clinical Factors Associated With Treatment Noncompliance in Euthymic Bipolar Patients. Francesc Colom, Eduard Vieta, Anabel Martinez-Aran, Maria Reinares, Antonio Benabarre, and Cristobal Gasto
[Abstract] [PDF]

556 Is Melatonin Treatment Effective for Tardive Dyskinesia? Eyal Shamir, Yoram Barak, Igor Plopsky, Nava Zisapel, Avner Elizur, and Abraham Weizman
[Abstract] [PDF]

559 A Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients. Paul A. Newhouse, K. Ranga Rama Krishnan, P. Murali Doraiswamy, Ellen M. Richter, Evan D. Batzar, and Cathryn M. Clary
[Abstract] [PDF]

569 Pisa Syndrome (Pleurothotonus): Report of a Multicenter Drug Safety Surveillance Project. Susanne Stubner, Frank Padberg, Renate Grohmann, Harald Hampel, Matthias Hollweg, Hanns Hippius, Hans-Jurgen Moller, and Eckart Ruther
[Abstract] [PDF]

575 An Open-Label Trial of St. John's Wort (Hypericum perforatum) in Obsessive-Compulsive Disorder. Leslie vH. Taylor and Kenneth A. Kobak
[Abstract] [PDF]

579 Predictors of Response to Sertraline Treatment of Severe Premenstrual Syndromes. Ellen W. Freeman, Steven J. Sondheimer, Marcia Polansky, and Beatriz Garcia-Espagna
[Abstract] [PDF]

585 Clinical and Biological Findings in a Case With 48-Hour Bipolar Ultrarapid Cycling Before and During Valproate Treatment. Georg Juckel, Ulrich Hegerl, Paraskevi Mavrogiorgou, Jurgen Gallinat, Torsten Mager, Peter Tigges, Stefan Dresel, Andreas Schroter, Gabriele Stotz, Ingeborg Meller, Waldemar Greil, and Hans-Jurgen Moller
[Abstract] [PDF]

594 Fluvoxamine Reduces the Clozapine Dosage Needed in Refractory Schizophrenic Patients. Mong-Liang Lu, Hsien-Yuan Lane, Kun-Po Chen, Michael W. Jann, Muh-Hwan Su, and Wen-Ho Chang
[Abstract] [PDF]

Academic Highlights

609 The Role of Mirtazapine in the Pharmacotherapy of Depression.
[PDF]

CME Article 617

618 Predictors of the Development of Phobic Avoidance. David A. Katerndahl
[Abstract] [PDF]

Letters to the Editor

600 Venlafaxine and Vivid Dreaming. Daniele F. Zullino and Francoise Riquier
[PDF]

600 Risperidone Metabolism and the Impact of Being a Cytochrome P450 2D6 Ultrarapid Metabolizer. Cuneyt Guzey, Trond Aamo, and Olav Spigset
[PDF]

601 Olanzapine-Induced Urinary Incontinence: Treatment With Ephedrine. Lance T. Vernon, Matthew A. Fuller, Helen Hattab, and Kathleen M. Varnes
[PDF]

602 Possible Connection Between Panic Disorder and Epilepsy. Jeffrey B. Weilburg
[PDF]

  • Reply by Peter P. Roy-Byrne

602 A Possible Case of Quetiapine Withdrawal Syndrome. Christian C. Thurstone and Peter Alahi
[PDF]

Book Reviews 604

Information for authors

see July 2000, pages 542544 or our Web site at http://www.psychiatrist.com/author.htm